Skip to main content

MoneyWorks4Me

Hester Biosciences submits analyst meet intimation

28 Oct 2026 Evaluate
Hester Biosciences has informed that, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has scheduled investor interaction through a teleconference call on Thursday, 5th November 2026 at 2:00 pm (IST), post the announcement of financial results for the quarter and six months period ended 30 September 2026. Details for joining the call are attached.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1769.00
Dr. Reddys Labs. 1355.70
Cipla 1378.30
Lupin 2024.50
Zydus Lifesciences 1238.95
View more..